Their interaction with HLA/MHC molecules on tumour cells and APCs contributes to the suppression of anti-tumour immunity, making them potential targets for therapeutic strategies aimed at enhancing immune responses against cancer (also see [188] for a recent comprehensive review). The gene discussed is HLA-C; the disease is neoplasm.